ADJUNCTIVE LEVETIRACETAM IN CHILDREN AND ADOLESCENTS AGED 4-16 YEARS WITH PARTIAL-ONSET SEIZURES: A LONG-TERM, MULTICENTER, NONCOMPARATIVE, OPEN-LABEL, FOLLOW-UP STUDY

被引：0
|
作者：
Yang, H. [1 ]
Schiemann, J. [1 ]
De la Loge, C. [2 ]
Stalvey, T. [1 ]
Jones, J. [1 ]
LeGoff, D. [3 ,4 ]
Mintz, M. [3 ,4 ]
机构：
[1] UCB Inc, Smyrna, GA USA
[2] UCB Pharma SA, Brussels, Belgium
[3] Ctr Neurol & Neurodev Hlth, Voorhees, NJ USA
[4] Clin Res Ctr New Jersey, Voorhees, NJ USA
来源：
EPILEPSIA | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] ADJUNCTIVE LEVETIRACETAM IN CHILDREN AGED 1 MONTH TO <4 YEARS WITH PARTIAL-ONSET SEIZURES: A LONG-TERM, MULTICENTER, NONCOMPARATIVE, OPEN-LABEL, FOLLOW-UP STUDY
    Pina-Garza, J.
    Schiemann, J.
    Yang, H.
    Duncan, B.
    Hadac, J.
    Hunter, S.
    EPILEPSIA, 2009, 50 : 101 - 102
  • [2] Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open-label, noncomparative, multicenter, long-term follow-up study
    Delanty, Norman
    Jones, John
    Tonner, Francoise
    EPILEPSIA, 2012, 53 (01) : 111 - 119
  • [3] LEVETIRACETAM IN CHILDREN, ADOLESCENTS AND ADULTS WITH PRIMARY GENERALIZED SEIZURES: OPEN-LABEL, NONCOMPARATIVE, MULTICENTER, LONG-TERM, FOLLOW-UP STUDY
    Delanty, N.
    Jones, J.
    Wash, M.
    Tonner, F.
    EPILEPSIA, 2009, 50 : 99 - 99
  • [4] A Long-Term Open-Label Extension Study Assessing Cognition and Behavior, Tolerability, Safety, and Efficacy of Adjunctive Levetiracetam in Children Aged 4 to 16 Years With Partial-Onset Seizures
    Schiemann-Delgado, Jimmy
    Yang, Haichen
    de la Loge, Christine
    Stalvey, Tracy J.
    Jones, John
    LeGoff, Daniel
    Mintz, Mark
    JOURNAL OF CHILD NEUROLOGY, 2012, 27 (01) : 80 - 89
  • [5] Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study
    Chung, Steve
    Ceja, Hugo
    Gawlowicz, Jacek
    McShea, Cindy
    Schiemann, Jimmy
    Lu, Sarah
    EPILEPSY RESEARCH, 2016, 120 : 7 - 12
  • [6] LEVETIRACETAM IN IDIOPATHIC GENERALIZED EPILEPSY SYNDROMES: OPEN-LABEL, NONCOMPARATIVE, MULTICENTER, LONG-TERM FOLLOW-UP STUDY
    Delanty, N.
    Jones, J.
    Tonner, F.
    EPILEPSIA, 2010, 51 : 118 - 118
  • [7] Long-Term Open-Label Study of Adjunctive Topiramate in Infants With Refractory Partial-Onset Seizures
    Puri, Vinay
    Ness, Seth
    Sattaluri, Sita Jayalakshmi
    Wang, Steven
    Todd, Mike
    Yuen, Eric
    Eerdekens, Marielle
    Nye, Jeffrey S.
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Ford, Lisa
    JOURNAL OF CHILD NEUROLOGY, 2011, 26 (10) : 1271 - 1283
  • [8] Adjunctive Levetiracetam in Patients Aged 1 Month to <4 Years With Partial-Onset Seizures: Subpopulation Analysis of a Prospective, Open-Label Extension Study of up to 48 Weeks
    Pina-Garza, Jesus Eric
    Schiemann-Delgado, Jimmy
    Yang, Haichen
    Duncan, Benjamin
    Hadac, Jan
    Hunter, Scott J.
    CLINICAL THERAPEUTICS, 2010, 32 (11) : 1935 - 1950
  • [9] Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years
    Rosenfeld, William
    Fountain, Nathan B.
    Kaubrys, Gintaras
    Ben-Menachemd, Elinor
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    EPILEPSY & BEHAVIOR, 2014, 41 : 164 - 170
  • [10] The KEEPER™1 trial:: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study
    Morrell, MJ
    Leppik, I
    French, J
    Ferrendelli, J
    Han, J
    Magnus, L
    EPILEPSY RESEARCH, 2003, 54 (2-3) : 153 - 161
12345